Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
IMITREX | GLAXOSMITHKLINE INC | Resolved | 20MG | Updated Report | 2024-11-02 | 241216 |
ZEPZELCA | JAZZ PHARMACEUTICALS IRELAND LIMITED | Actual shortage | 4MG | Updated Report | 2024-11-02 | 234751 |
TOBI PODHALER | BGP PHARMA ULC | Actual shortage | 28MG | Updated Report | 2024-11-02 | 236492 |
ZYCLARA | BAUSCH HEALTH, CANADA INC. | Actual shortage | 3.75% | Updated Report | 2024-11-02 | 237210 |
TEGRETOL CR | NOVARTIS PHARMACEUTICALS CANADA INC | Resolved | 400MG | Updated Report | 2024-11-02 | 239094 |
SUPREFACT DEPOT 2 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 6.3MG | Updated Report | 2024-11-02 | 240203 |
DIHYDROERGOTAMINE (DHE), 1MG/ML | STERIMAX INC | Actual shortage | 1MG | Updated Report | 2024-11-02 | 239039 |
POTASSIUM PHOSPHATES INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 236MG 224MG | Updated Report | 2024-11-02 | 240890 |
FENTANYL INJECTION BP | STERIMAX INC | Actual shortage | 100MCG | Updated Report | 2024-11-02 | 241701 |
GLICLAZIDE MR | SANIS HEALTH INC | Actual shortage | 30MG | Updated Report | 2024-11-02 | 241793 |
NAT-EVEROLIMUS | NATCO PHARMA (CANADA) INC | Actual shortage | 5MG | Updated Report | 2024-11-02 | 241865 |
NAT-EVEROLIMUS | NATCO PHARMA (CANADA) INC | Actual shortage | 10MG | Updated Report | 2024-11-02 | 241868 |
CLARUS | MYLAN PHARMACEUTICALS ULC | Actual shortage | 40MG | Updated Report | 2024-11-02 | 241465 |
VENTOLIN RESPIRATOR SOLUTION | GLAXOSMITHKLINE INC | Resolved | 5MG | Updated Report | 2024-11-01 | 177586 |
APO-CEFEPIME | APOTEX INC | Actual shortage | 1G | Updated Report | 2024-11-01 | 238245 |
MYXREDLIN | BAXTER CORPORATION | Actual shortage | 1UNIT | Updated Report | 2024-11-01 | 241104 |
TEVA-ESOMEPRAZOLE | TEVA CANADA LIMITED | Resolved | 40MG | Updated Report | 2024-11-01 | 231430 |
TEVA-RAMIPRIL | TEVA CANADA LIMITED | Resolved | 2.5MG | Updated Report | 2024-11-01 | 234882 |
TEVA-RAMIPRIL | TEVA CANADA LIMITED | Resolved | 5MG | Updated Report | 2024-11-01 | 236808 |
TEVA-PRAVASTATIN | TEVA CANADA LIMITED | Resolved | 10MG | Updated Report | 2024-11-01 | 229948 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
DORZOLAMIDE AND TIMOLOL EYE DROPS BP | HIKMA CANADA LIMITED | Discontinued | 5MG 20MG | New Report | 2024-11-01 | 241852 |
PEDIACEL | SANOFI PASTEUR LIMITED | Discontinued | 5MCG 20MCG 30MCG 10MCG 26UNIT 7UNIT 29UNIT 5LF 15LF 20MCG 3MCG | New Report | 2024-11-01 | 241815 |
DALACIN C 300 MG | PFIZER CANADA ULC | Discontinued | 300MG | Updated Report | 2024-10-30 | 241493 |
PANTOPRAZOLE SODIUM FOR INJECTION | SANDOZ CANADA INCORPORATED | Discontinued | 40MG | New Report | 2024-10-29 | 241520 |
HUMALOG | ELI LILLY CANADA INC | To be discontinued | 100UNIT | Updated Report | 2024-10-29 | 224347 |
IMDUR | JUNO PHARMACEUTICALS CORP. | Discontinued | 60MG | Updated Report | 2024-10-29 | 233587 |
TD ADSORBED | SANOFI PASTEUR LIMITED | Discontinued | 5LF 2LF | Updated Report | 2024-10-25 | 206909 |
HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 24MG 3.15ML | New Report | 2024-10-18 | 240682 |
HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 12MG 3.15ML | New Report | 2024-10-18 | 240679 |
HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 6MG 3.15ML | New Report | 2024-10-18 | 240676 |